IS1564B - Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar - Google Patents

Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar

Info

Publication number
IS1564B
IS1564B IS3156A IS3156A IS1564B IS 1564 B IS1564 B IS 1564B IS 3156 A IS3156 A IS 3156A IS 3156 A IS3156 A IS 3156A IS 1564 B IS1564 B IS 1564B
Authority
IS
Iceland
Prior art keywords
preparation
therapeutic use
benzimidazole derivatives
substituted benzimidazole
compounds
Prior art date
Application number
IS3156A
Other languages
English (en)
Other versions
IS3156A7 (is
Inventor
Börje Alminger Tomas
Sigurd Larsson Håkan
Lennart Lindberg Per
Elisabeth Sundén Gunnel
Original Assignee
Aktiebolaget Hässle
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aktiebolaget Hässle filed Critical Aktiebolaget Hässle
Publication of IS3156A7 publication Critical patent/IS3156A7/is
Publication of IS1564B publication Critical patent/IS1564B/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
IS3156A 1985-10-29 1986-10-28 Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar IS1564B (is)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8505112A SE8505112D0 (sv) 1985-10-29 1985-10-29 Novel pharmacological compounds

Publications (2)

Publication Number Publication Date
IS3156A7 IS3156A7 (is) 1987-04-30
IS1564B true IS1564B (is) 1994-12-13

Family

ID=20361960

Family Applications (1)

Application Number Title Priority Date Filing Date
IS3156A IS1564B (is) 1985-10-29 1986-10-28 Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar

Country Status (31)

Country Link
US (1) US5021433A (is)
EP (2) EP0221041A3 (is)
JP (2) JPH0780874B2 (is)
KR (1) KR950009858B1 (is)
CN (1) CN1022487C (is)
AT (1) ATE79619T1 (is)
AU (1) AU598491B2 (is)
CS (1) CS272767B2 (is)
DD (1) DD252375A5 (is)
DE (1) DE3686483T2 (is)
DK (1) DK320587D0 (is)
EG (1) EG17753A (is)
ES (1) ES2051696T3 (is)
FI (1) FI91151C (is)
GR (1) GR3006177T3 (is)
HU (1) HU198474B (is)
IE (1) IE59167B1 (is)
IL (1) IL80437A0 (is)
IS (1) IS1564B (is)
JO (1) JO1502B1 (is)
LT (1) LTIP1681A (is)
LV (1) LV10270B (is)
MY (1) MY101791A (is)
NO (1) NO171365C (is)
NZ (1) NZ218028A (is)
PH (1) PH25319A (is)
PL (1) PL150240B1 (is)
PT (1) PT83647B (is)
SE (1) SE8505112D0 (is)
WO (1) WO1987002668A1 (is)
ZA (1) ZA867716B (is)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ234564A (en) * 1986-11-21 1991-04-26 Haessle Ab 1-substituted benzimidazoles and pharmaceutical compositions
EP0436025A4 (en) * 1988-09-20 1991-09-11 Hisamitsu Pharmaceutical Co. Inc. Novel dibenz b,e)oxepin derivatives
EG19302A (en) * 1988-12-22 1994-11-30 Haessle Ab Compound with gastric acid inhibitory effect and process for its preparation
SE8804629D0 (sv) * 1988-12-22 1988-12-22 Ab Haessle New therapeutically active compounds
US4965269A (en) * 1989-12-20 1990-10-23 Ab Hassle Therapeutically active chloro substituted benzimidazoles
US5274099A (en) * 1989-12-20 1993-12-28 Aktiebolaget Hassle Therapeutically active fluoro substituted benzimidazoles
US5049674A (en) * 1989-12-20 1991-09-17 Aktiebolaget Hassle Therapeutically active fluoro substituted benzimidazoles
SE9002206D0 (sv) 1990-06-20 1990-06-20 Haessle Ab New compounds
AU649456B2 (en) * 1990-06-20 1994-05-26 Astra Aktiebolag Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use
ES2048109B1 (es) * 1992-07-20 1994-12-16 Espanola Prod Quimicos Procedimiento de preparacion de nuevos derivados piperidicos del bencimidazol.
WO1995032957A1 (en) * 1994-05-27 1995-12-07 Astra Aktiebolag Novel ethoxycarbonyloxymethyl derivatives of substituted benzimidazoles
US6093734A (en) * 1998-08-10 2000-07-25 Partnership Of Michael E. Garst, George Sachs, And Jai Moo Shin Prodrugs of proton pump inhibitors
HRP20010106A2 (en) 1998-08-10 2002-02-28 Partnership Of Michael E Garst Prodrugs of proton pump inhibitors
US6852739B1 (en) 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
US6369087B1 (en) * 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
WO2002030920A1 (en) * 2000-10-12 2002-04-18 Takeda Chemical Industries, Ltd. Benzimidazole compounds, process for producing the same and use thereof
EP1437352A4 (en) * 2001-09-25 2004-12-08 Takeda Chemical Industries Ltd BENZIMIDAZOLE COMPOUND, METHOD FOR THE PRODUCTION AND USE THEREOF
US7410981B2 (en) * 2002-06-14 2008-08-12 Takeda Pharmaceutical Company Limited Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e.g. peptic ulcers
PL375255A1 (en) * 2002-07-19 2005-11-28 Winston Pharmaceuticals Llc Prodrugs of proton pump inhibitors
WO2004012659A2 (en) 2002-08-01 2004-02-12 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
MY148805A (en) 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
US8802139B2 (en) * 2003-06-26 2014-08-12 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
WO2005039640A1 (en) * 2003-10-03 2005-05-06 Allergan Inc. Compositions comprising trefoil factor family peptides and/or mucoadhesives and proton pump inhibitor prodrugs
US20050075371A1 (en) * 2003-10-03 2005-04-07 Allergan, Inc. Methods and compositions for the oral administration of prodrugs of proton pump inhibitors
JP2007523164A (ja) * 2004-02-18 2007-08-16 アラーガン、インコーポレイテッド プロトンポンプインヒビターに関連する化合物の静脈内投与のための方法および組成物
CA2556756A1 (en) * 2004-02-18 2005-09-09 Allergan, Inc. Compositions comprising prodrugs of proton pump inhibitors
WO2005117870A2 (en) * 2004-04-16 2005-12-15 Santarus, Inc. Combination of proton pump inhibitor, buffering agent, and prokinetic agent
ATE437869T1 (de) * 2004-04-28 2009-08-15 Hetero Drugs Ltd Verfahren zur herstellung von pyridinylmethyl-1h- benzimidazolverbindungen in enantiomerenangereicherter form oder als einzelne enantiomere
US7365206B2 (en) 2004-05-28 2008-04-29 Hetero Drugs Limited Stereoselective synthesis of benzimidazole sulfoxides
US8394409B2 (en) * 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
US9561188B2 (en) * 2006-04-03 2017-02-07 Intellipharmaceutics Corporation Controlled release delivery device comprising an organosol coat
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
WO2008036201A1 (en) * 2006-09-19 2008-03-27 Alevium Pharmaceuticals, Inc. Prodrugs of proton pump inhibitors including the 1h-imidazo[4,5-b] pyridine moiety
WO2008057802A2 (en) 2006-10-27 2008-05-15 The Curators Of The University Of Missouri Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same
US20080194307A1 (en) * 2007-02-13 2008-08-14 Jeff Sanger Sports-based game of chance
US8247440B2 (en) 2008-02-20 2012-08-21 Curators Of The University Of Missouri Composition comprising omeprazole, lansoprazole and at least one buffering agent
AU2010339691B2 (en) * 2010-01-07 2015-04-02 Alkermes Pharma Ireland Limited Prodrugs of heteraromatic compounds

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4045564A (en) * 1974-02-18 1977-08-30 Ab Hassle Benzimidazole derivatives useful as gastric acid secretion inhibitors
SE418966B (sv) * 1974-02-18 1981-07-06 Haessle Ab Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan
SE416649B (sv) * 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
IN148930B (is) * 1977-09-19 1981-07-25 Hoffmann La Roche
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US4359465A (en) * 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
CH644116A5 (de) * 1980-08-21 1984-07-13 Hoffmann La Roche Imidazolderivate.
SE8300736D0 (sv) * 1983-02-11 1983-02-11 Haessle Ab Novel pharmacologically active compounds
IL75400A (en) * 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
AU568441B2 (en) * 1984-09-24 1987-12-24 Upjohn Company, The 2-(pyridylalkenesulfinyl) benzimidazole derivatives
ZA856671B (en) * 1984-09-24 1986-04-30 Upjohn Co N-substituted derivatives of 2-(pyridylaklenesulfinyl)benzimidazoles as gastric antisecretory agents

Also Published As

Publication number Publication date
DK320587A (da) 1987-06-24
NO171365C (no) 1993-03-03
AU598491B2 (en) 1990-06-28
CN86107595A (zh) 1987-07-08
LV10270A (lv) 1994-10-20
CS782686A2 (en) 1990-05-14
PH25319A (is) 1991-04-30
ES2051696T3 (es) 1994-07-01
PL150240B1 (en) 1990-05-31
FI872864L (fi) 1987-06-29
NO872686D0 (no) 1987-06-26
PL262105A1 (en) 1988-08-18
FI872864A0 (fi) 1987-06-29
FI91151C (sv) 1994-05-25
IE59167B1 (en) 1994-01-12
EP0221041A3 (en) 1987-10-28
EP0221041A2 (en) 1987-05-06
JPH07188216A (ja) 1995-07-25
LTIP1681A (en) 1995-09-25
HU198474B (en) 1989-10-30
NO171365B (no) 1992-11-23
WO1987002668A1 (en) 1987-05-07
IE862805L (en) 1987-04-29
CN1022487C (zh) 1993-10-20
LV10270B (en) 1995-04-20
CS272767B2 (en) 1991-02-12
JO1502B1 (en) 1989-01-25
FI91151B (fi) 1994-02-15
KR950009858B1 (ko) 1995-08-29
ATE79619T1 (de) 1992-09-15
PT83647A (en) 1986-11-01
MY101791A (en) 1992-01-31
JPH0826014B2 (ja) 1996-03-13
US5021433A (en) 1991-06-04
EG17753A (en) 1991-12-30
EP0233284A1 (en) 1987-08-26
AU6542986A (en) 1987-05-19
PT83647B (pt) 1989-05-31
JPH0780874B2 (ja) 1995-08-30
KR870700620A (ko) 1987-12-30
HUT43843A (en) 1987-12-28
SE8505112D0 (sv) 1985-10-29
DE3686483T2 (de) 1993-02-04
NZ218028A (en) 1990-02-26
IL80437A0 (en) 1987-01-30
EP0233284B1 (en) 1992-08-19
DK320587D0 (da) 1987-06-24
JPS63501151A (ja) 1988-04-28
ZA867716B (en) 1987-05-27
DD252375A5 (de) 1987-12-16
IS3156A7 (is) 1987-04-30
NO872686L (no) 1987-06-26
DE3686483D1 (de) 1992-09-24
GR3006177T3 (is) 1993-06-21

Similar Documents

Publication Publication Date Title
IS1564B (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
IS3284A7 (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
DK233586A (da) 5-substituerede 1,3-thiazolidon-2,4-dion forbindelser og farmaceutiske praeparater indeholdende disse
MX9203417A (es) Compuestos de diarilo antiateroescleroticos.
SE8404065D0 (sv) Novel biologically active compounds
IT1224405B (it) Composti attivi sul sistema cardiovascolare
SE8600658D0 (sv) Novel composition of matter
IT1226897B (it) Derivato di taurina, sua preparazione e composizioni farmaceutiche relative
IT1224404B (it) Composti attivi sul sistema cardiovascolare
SE8704049D0 (sv) Novel pharmacological compounds
JO1519B1 (en) New compounds (new benzimidazole derivatives are effective as ulcers)